EUVIMEDEUVIMED entdecken
Crossref

Catalpol protects against MPP+-induced neurotoxicity by targeting PINK1/DJ-1-mediated mitophagy and the TrkB/Akt/BDNF/Bcl-2 axis

Han-Bin Yang, Yi-Hung Chen, Nguyen Thi Thao Nhung, En-Ya Hung, Shih-Ya Hung

Neurochemistry International · 2026-10 · 199 · 106235

DOI: 10.1016/j.neuint.2026.106235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2026-10. Verfasst von Han-Bin Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Acupuncture Science, China Medical University, Taichung, 404328, Taiwan. Hauptthemen laut MEDLINE: Neuroprotective Agents, 1-Methyl-4-phenylpyridinium, Iridoid Glucosides, Protein Kinases. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Science and Technology Council, China Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by dopaminergic neuronal death of unclear etiology. While levodopa remains the gold standard for managing PD motor symptoms, it lacks disease-modifying efficacy, necessitating new neuroprotective therapies. Mitochondrial dysfunction and impaired autophagy are key hallmarks of PD. This study utilized 1-methyl-4-phenylpyridinium (MPP+)-treated SH-SY5Y cells to investigate the neuroprotective mechanisms of catalpol, an iridoid glycoside derived from Rehmannia glutinosa. We found that catalpol attenuated MPP+-induced neurotoxicity, mitochondrial membrane depolarization, and ATP depletion. This protection was critically dependent on autophagy; it was enhanced by the activator rapamycin but abolished by the inhibitor wortmannin and the autophagosome-lysosome fusion inhibitor bafilomycin A1. Catalpol activated autophagy by increasing autophagosome formation, elevating Beclin 1 and LC3-II levels, and promoting p62 degradation. Furthermore, catalpol reversed MPP+-induced mitophagy suppression and restored the regulatory protein PINK1 and DJ-1 expression. Given that Akt/BDNF/Bcl-2 and TrkB/BDNF pathways promote neuronal survival, we investigated their involvement. We found that the TrkB agonist 7,8-DHF mimicked catalpol's neuroprotection against MPP+-induced neurotoxicity, whereas the pan-Trk inhibitor GNF-5837 abolished it. Western blotting demonstrated that catalpol reversed MPP+-mediated suppression of TrkB and Akt phosphorylation, as well as BDNF and Bcl-2 expression. Molecular docking indicated that catalpol may interact with the TrkB ligand-binding domain as 7,8-DHF and shares key binding residues. Our findings suggest that catalpol exerts neuroprotection via a dual mechanism: preserving mitochondrial function through PINK1/DJ-1-mediated mitophagy and activating the TrkB/Akt/BDNF/Bcl-2 survival pathway, potentially by interacting with the TrkB receptor, highlighting its therapeutic potential for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective Agents1-Methyl-4-phenylpyridiniumIridoid GlucosidesProtein KinasesMitophagyHumansProto-Oncogene Proteins c-aktPTEN-Induced Putative KinaseProto-Oncogene Proteins c-bcl-2Brain-Derived Neurotrophic FactorReceptor, trkBSignal TransductionCell Line, TumorMembrane Glycoproteins

Stichwörter der Autor:innen

CatalpolMitophagyNeuroprotectionParkinson's diseaseTrkB/Akt/BDNF/Bcl-2 axis

Substanzen

catalpolNeuroprotective Agents1-Methyl-4-phenylpyridiniumIridoid GlucosidesProtein KinasesProto-Oncogene Proteins c-aktPTEN-Induced Putative KinaseProto-Oncogene Proteins c-bcl-2Brain-Derived Neurotrophic FactorReceptor, trkB

Autor:innen und Institutionen

  • Graduate Institute of Acupuncture Science, China Medical University, Taichung, 404328, Taiwan.
  • The International Master Program in Integrative Health, China Medical University, Taichung, 404328, Taiwan.
  • Department of Biological Science and Technology, China Medical University, Taichung, 406040, Taiwan.
  • Graduate Institute of Acupuncture Science, China Medical University, Taichung, 404328, Taiwan; Division of Surgery, Department of Medical Research, China Medical University Hospital, Taichung, 404327, Taiwan. Electronic…

Förderung

  • National Science and Technology Council
  • China Medical University Hospital

Zitieren

APA

Yang, H. B., Chen, Y. H., Nhung, N. T. T., Hung, E. Y., & Hung, S. Y. (2026). Catalpol protects against MPP+-induced neurotoxicity by targeting PINK1/DJ-1-mediated mitophagy and the TrkB/Akt/BDNF/Bcl-2 axis. Neurochemistry International, 199, 106235. https://doi.org/10.1016/j.neuint.2026.106235

Vancouver

Yang HB, Chen YH, Nhung NTT, Hung EY, Hung SY. Catalpol protects against MPP+-induced neurotoxicity by targeting PINK1/DJ-1-mediated mitophagy and the TrkB/Akt/BDNF/Bcl-2 axis. Neurochemistry International. 2026;199:106235. doi:10.1016/j.neuint.2026.106235

BibTeX
@article{Yang2026,
  author = {Yang, Han-Bin and Chen, Yi-Hung and Nhung, Nguyen Thi Thao and Hung, En-Ya and Hung, Shih-Ya},
  title = {Catalpol protects against MPP+-induced neurotoxicity by targeting PINK1/DJ-1-mediated mitophagy and the TrkB/Akt/BDNF/Bcl-2 axis},
  journal = {Neurochemistry International},
  year = {2026},
  volume = {199},
  pages = {106235},
  doi = {10.1016/j.neuint.2026.106235}
}
Kostenlos starten →